Principal Financial Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.29M | Buy |
230,610
+17,194
| +8% | +$543K | ﹤0.01% | 1408 |
|
|
2025
Q1 | $7.08M | Buy |
213,416
+4,753
| +2% | +$158K | ﹤0.01% | 1425 |
|
|
2024
Q4 | $7.18M | Buy |
208,663
+46,194
| +28% | +$1.59M | ﹤0.01% | 1450 |
|
|
2024
Q3 | $6.5M | Sell |
162,469
-19,654
| -11% | -$786K | ﹤0.01% | 1473 |
|
|
2024
Q2 | $5.49M | Sell |
182,123
-9,927
| -5% | -$299K | ﹤0.01% | 1527 |
|
|
2024
Q1 | $6.45M | Sell |
192,050
-5,994
| -3% | -$201K | ﹤0.01% | 1489 |
|
|
2023
Q4 | $6.4M | Sell |
198,044
-1,706
| -0.9% | -$55.1K | ﹤0.01% | 1477 |
|
|
2023
Q3 | $6.55M | Buy |
199,750
+16,260
| +9% | +$533K | ﹤0.01% | 1427 |
|
|
2023
Q2 | $6.46M | Sell |
183,490
-3,173
| -2% | -$112K | ﹤0.01% | 1437 |
|
|
2023
Q1 | $6.09M | Sell |
186,663
-5,691
| -3% | -$186K | ﹤0.01% | 1468 |
|
|
2022
Q4 | $10.6M | Sell |
192,354
-5,622
| -3% | -$310K | 0.01% | 1213 |
|
|
2022
Q3 | $8.77M | Buy |
197,976
+7,145
| +4% | +$316K | 0.01% | 1259 |
|
|
2022
Q2 | $9.31M | Sell |
190,831
-4,907
| -3% | -$239K | 0.01% | 1298 |
|
|
2022
Q1 | $9.52M | Buy |
195,738
+37,181
| +23% | +$1.81M | 0.01% | 1403 |
|
|
2021
Q4 | $6.76M | Buy |
+158,557
| New | +$6.76M | ﹤0.01% | 1562 |
|